Clearside Biomedical, Inc.·4

Jun 4, 8:31 PM ET

White Daniel H. 4

4 · Clearside Biomedical, Inc. · Filed Jun 4, 2018

Insider Transaction Report

Form 4
Period: 2018-03-28
White Daniel H.
DirectorPresident and CEO
Transactions
  • Purchase

    Common Stock

    2018-06-04$9.07/sh+11,000$99,770483,335 total
  • Gift

    Common Stock

    2018-03-282,000472,335 total
Holdings
  • Common Stock

    (indirect: As UTMA custodian for son)
    301
  • Common Stock

    (indirect: As UTMA custodian for son)
    1,188
  • Common Stock

    (indirect: By Trust)
    35,309
  • Common Stock

    (indirect: As UTMA custodian for son)
    844
Footnotes (3)
  • [F1]This transaction was executed in multiple trades at prices ranging from $9.04 to $9.07, inclusive. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
  • [F2]These securities are held in trust for the benefit of the reporting person's children. The reporting person's wife serves as trustee of the trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
  • [F3]These securities are held for the benefit of the reporting person's son under the Georgia Uniform Transfers to Minors Act, for which the reporting person serves as custodian. The reporting person disclaims beneficial ownership of these shares, and this report shall not be deemed an admission that the reporting person is the beneficial owner of these shares for purposes of Section 16 or for any other purpose.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION